New sunscreen ingredient could soon be allowed in the US
Americans may soon have access to a new sunscreen ingredient already used around the world.
Dec 12, 2025
0
14
Americans may soon have access to a new sunscreen ingredient already used around the world.
Dec 12, 2025
0
14
A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular mechanism that contributes to the development of psoriasis—and at the same time represents a potential ...
Dec 11, 2025
0
55
It's pretty normal to wear the same pair of jeans, a jumper or even a t-shirt more than once. But what about your socks?
Dec 8, 2025
0
29
Most of us know sunscreen is a key way to protect areas of our skin not easily covered by clothes from excessive ultraviolet (UV) radiation.
Dec 5, 2025
0
11
It's well known that stress can trigger hair loss. A new paper explores how this happens and how our response to stress can have long-term consequences for our scalps, research that may eventually yield insights into autoimmune ...
Dec 3, 2025
0
30
A new study from researchers at the University of Otago, Faculty of Medicine—Christchurch Ōtautahi, has found that collagen production and skin renewal directly respond to the amount of vitamin C we eat.
Dec 3, 2025
0
25
A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), which mostly affects skin folds, is believed to be the first to provide evidence that hormone-disrupting ...
Dec 1, 2025
0
64
Talc-based makeup and powders will not go through new asbestos testing requirements after the U.S. Food and Drug Administration (FDA) chose to pull back a proposed rule last week.
Dec 1, 2025
0
17
"Mineral-only" sunscreens are making huge inroads into the sunscreen market, driven by fears of "chemicals," a belief that "mineral" products are inherently safer, and confusion about how sunscreens actually protect our skin.
Dec 1, 2025
0
16
An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).
Nov 27, 2025
0
39